Pandect Bioventures
Venture capitalWoodside · Seed–Late Stage · 10 people tracked
Find your way into Pandect Bioventures
4 people in our graph share verified history with the Pandect Bioventures team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Pandect Bioventures focuses on transformational healthcare and life science opportunities at the earliest stage. It leverages an ecosystem of a 40,000 square foot incubator facility, exclusive relationships with research institutions, and experienced academic and industry advisors to source and grow investments. Executives-in-residence and management bring decades of operating experience to portfolio companies. Opportunities are evaluated through a rigorous assessment process, with funding spanning seed, Series A, and later rounds. The firm frequently co-invests alongside other life science investors and forms new companies with academic co-founders drawn from leading research institutions.
Source: firm website, verified Sep 1, 2026.
Team · 10 people
from the firm's website & public directories
What they invest in
from 5 of 5 portfolio companiesBiotech ×5Medical Devices ×5Healthtech ×2AI & Machine Learning ×1Deep Tech ×1Digital Health ×1
HQs:United States×3
Investments · 5 tracked
founders shown can be your intro pathBy year:2024 · 12022 · 12 dated
Circle Pharma develops cancer treatments using macrocycle therapies designed to reduce side effects compared to conventional therapies.
BiotechDigital HealthHealthtechMedical DevicesSouth San Francisco, US
Matthew P. Jacobson(Co-founder)Scott R. Lokey(Director)David J. Earp(President & CEO)inPaul Park(Executive Officer)
BoardThilo Schroeder(Director)in
Board seatWalter H. Moos· per SEC Form D
Co-investorsBerkeley CatalystLifeforce CapitalMission Bay CapitalMission BiocapitalNextech InvestThe Column Group+1 more
Azkarra Therapeutics develops small molecule drugs targeting DNA damage repair and immune response pathways for cancer and inflammatory diseases.
BiotechDeep TechMedical Devices
Alan Ashworth(Founder)
Valitor develops bioactive molecule therapies using a multivalent biopolymer technology platform to create long-acting treatments for ophthalmologic diseases, with its lead candidate VLTR-559 targeting wet age-related macular degeneration.
BiotechMedical DevicesBerkeley, US
Wesley Jackson(President, Chief Scientific Officer & Member of the Board)inGregory D. Kunst(Chief Executive Officer)Carole H Bellis(Executive Officer)Kevin E Healy(Director)Jackson M Wesley(Executive Officer, Director)
BoardDrew Lanza(Director)in
Co-investorsAngel Physicians FundBerkeley CatalystExSight VenturesFirst Spark Ventures, LlcExSight
Walden Biosciences is a clinical-stage biotech company developing disease-modifying therapies that selectively target the kidney to treat the underlying drivers of kidney disease.
BiotechMedical Devices
Co-investorsARCH Venture Partners
Walking Fish Therapeutics develops cell therapies aimed at restoring health and function in patients.
AI & Machine LearningBiotechHealthtechMedical DevicesSouth San Francisco, US
Lewis Williams(Co-founder & CEO)inRusty Williams(Founder)Antonin de Fougerolles(Director)Momo Wu(Director)Stella Xu(Director)Alexis Ji(Director)
Co-investorsFirst Spark Ventures, LlcNorthpond Ventures
Frequently asked questions
- How many investments has Pandect Bioventures made?
- Pandect Bioventures has 5 tracked investments.
- What stage does Pandect Bioventures invest at?
- Pandect Bioventures invests at the Seed, Series A, Series B, Series C, Late Stage stages.
- What sectors does Pandect Bioventures focus on?
- Pandect Bioventures focuses on Biotech, Healthtech, Longevity, Medical Devices.
- Where is Pandect Bioventures located?
- Pandect Bioventures is headquartered in Woodside, US.
- Who does Pandect Bioventures co-invest with?
- Pandect Bioventures most often shares deals with Berkeley Catalyst, ARCH Venture Partners, First Spark Ventures, Llc, among 11 tracked co-investors.
Similar investors
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.
Foresite Capital is a healthcare-focused investment firm backing companies at the intersection of technology and biotechnology to personalize healthcare and accelerate medical innovation.
Pontifax is an investment firm focused on life sciences and healthcare technologies, backing companies across all development stages from early research to clinical-stage growth.
EQT Life Sciences, formerly LSP, is one of Europe's largest and most experienced life sciences investors, backing companies developing therapeutics, medical devices, diagnostics and healthtech globally. It is part of EQT Group.